These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8573762)

  • 1. SH2 and SH3 domains: potential targets for anti-cancer drug design.
    Smithgall TE
    J Pharmacol Toxicol Methods; 1995 Nov; 34(3):125-32. PubMed ID: 8573762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation.
    Hu KQ; Settleman J
    EMBO J; 1997 Feb; 16(3):473-83. PubMed ID: 9034330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase signalling pathways.
    Pawson T
    Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction.
    Birge RB; Knudsen BS; Besser D; Hanafusa H
    Genes Cells; 1996 Jul; 1(7):595-613. PubMed ID: 9078388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH2 and SH3 domains as targets for anti-proliferative agents.
    Vidal M; Gigoux V; Garbay C
    Crit Rev Oncol Hematol; 2001 Nov; 40(2):175-86. PubMed ID: 11682324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of connexin 43 by v-Src is mediated by SH2 and SH3 domain interactions.
    Kanemitsu MY; Loo LW; Simon S; Lau AF; Eckhart W
    J Biol Chem; 1997 Sep; 272(36):22824-31. PubMed ID: 9278444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.
    Koch CA; Anderson D; Moran MF; Ellis C; Pawson T
    Science; 1991 May; 252(5006):668-74. PubMed ID: 1708916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH2/SH3 signaling proteins.
    Schlessinger J
    Curr Opin Genet Dev; 1994 Feb; 4(1):25-30. PubMed ID: 8193536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific intermolecular association between the regulatory domains of a Tec family kinase.
    Brazin KN; Fulton DB; Andreotti AH
    J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteins with SH2 and SH3 domains couple receptor tyrosine kinases to intracellular signalling pathways.
    Pawson T; Olivier P; Rozakis-Adcock M; McGlade J; Henkemeyer M
    Philos Trans R Soc Lond B Biol Sci; 1993 Jun; 340(1293):279-85. PubMed ID: 8103930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
    Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
    Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
    Liu SK; McGlade CJ
    Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation.
    Young MA; Gonfloni S; Superti-Furga G; Roux B; Kuriyan J
    Cell; 2001 Apr; 105(1):115-26. PubMed ID: 11301007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation: new aspects.
    Fox JE
    Haemostasis; 1996 Oct; 26 Suppl 4():102-31. PubMed ID: 8979117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
    Lerner EC; Smithgall TE
    Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk SH3 domain.
    Severin A; Joseph RE; Boyken S; Fulton DB; Andreotti AH
    J Mol Biol; 2009 Apr; 387(3):726-43. PubMed ID: 19361414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Src homology 2 domain of the protein-tyrosine kinase p56lck mediates both intermolecular and intramolecular interactions.
    Amrein KE; Panholzer B; Flint NA; Bannwarth W; Burn P
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10285-9. PubMed ID: 7694287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.